Overview of vasculitis and vasculopathy in rheumatoid arthritis - Something to think about

Clinical Rheumatology

Volumn 32, Issue 7, 2013, Pages 937-942

  Radic, Mislav ^a   Kaliterna, Dusanka Martinovic ^a   Radic, Josipa ^a  

^a UNIVERSITY OF SPLIT   (Croatia)

Author keywords

Atherosclerosis; Rheumatoid arthritis; Rheumatoid vasculitis

Indexed keywords

ABATACEPT; AZATHIOPRINE; C REACTIVE PROTEIN; CHLOROQUINE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; HLA C ANTIGEN; HLA DRB1 ANTIGEN; HYDROXYCHLOROQUINE; INFLIXIMAB; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; RHEUMATOID FACTOR; RITUXIMAB; TOCILIZUMAB; TRIACYLGLYCEROL;

ANTIGEN ANTIBODY COMPLEX; ANTIINFLAMMATORY ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CD4+ T LYMPHOCYTE; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; DYSLIPIDEMIA; ENDOTHELIUM CELL; FINGER ULCER; FUNCTIONAL DISEASE; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; IMMOBILIZATION; INFLUENZA VACCINATION; LEG ULCER; LIFE EXPECTANCY; LIPID OXIDATION; MAST CELL; MICROANEURYSM; MONONEUROPATHY; MONONEUROPATHY MULTIPLEX; MUSCLE WEAKNESS; OBESITY; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; RHEUMATOID VASCULITIS; RISK REDUCTION; SMOKING; SYSTEMIC VASCULITIS; VASCULAR DISEASE; VASCULARIZATION;

ALLELES; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; EPITOPES; HUMANS; INFLAMMATION; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; RISK FACTORS; VASCULAR DISEASES; VASCULITIS;

EID: 84880176837     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2273-8     Document Type: Conference Paper

References (50)

1. Szekanecz Z, Koch AE (2008) Vascular involvement in rheumatic diseases: 'vascular rheumatology'. Arthritis Res Ther 10(5):224
2. Kitas GD, Gabriel SE (2011) Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis 70(1):8-14
3. Puechal X, Said G, Hilliquin P, Coste J, Job-Deslandre C, Lacroix C et al (1995) Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 38(11):1618-29
4. Scott DG, Bacon PA, Tribe CR (1981) Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 60(4):288-97 (Pubitemid 11079845)
5. Pagnoux C, Mahr A, Cohen P, Guillevin L (2005) Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 84(2):115-28 (Pubitemid 40418640)
6. Scott DGI, Bacon PA, Allen C, Elson CJ, Wallington T (1981) Igg rheumatoid-factor, complement and immune-complexes in rheumatoid synovitis and vasculitis - comparative and serial studies during cyto-toxic therapy. Clin Exp Immunol 43(1):54-63 (Pubitemid 11196780)
7. Turesson C, Jacobsson LT, Sturfelt G, Matteson EL, Mathsson L, Ronnelid J (2007) Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 66(1):59-64 (Pubitemid 46044861)
8. Watts RA, Carruthers DM, Symmons DP, Scott DG (1994) The incidence of rheumatoid vasculitis in the Norwich Health Authority. Br J Rheumatol 33(9):832-3 (Pubitemid 24283221)
9. Voskuyl AE, van Duinen SG, Zwinderman AH, Breedveld FC, Hazes JM (1998) The diagnostic value of perivascular infiltrates in muscle biopsy specimens for the assessment of rheumatoid vasculitis. Ann Rheum Dis 57(2):114-7 (Pubitemid 28177542)
10. Turesson C, McClelland RL, Christianson T, Matteson E (2008) Clustering of extraarticular manifestations in patients with rheumatoid arthritis. J Rheumatol 35(1):179-80
11. Struthers GR, Scott DL, Delamere JP, Sheppeard H, Kitt M (1981) Smoking and rheumatoid vasculitis. Rheumatol Int 1(3):145-6 (Pubitemid 12164052)
12. Turesson C, Schaid DJ, Weyand CM, Jacobsson LT, Goronzy JJ, Petersson IF et al (2006) Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis. Arthritis Rheum 54(9):2776-83 (Pubitemid 44497756)
13. Turesson C, Schaid DJ, Weyand CM, Jacobsson LT, Goronzy JJ, Petersson IF et al (2005) The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res Ther 7(6):R1386-93
14. Gorman JD, David-Vaudey E, Pai M, Lum RF, Criswell LA (2004) Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum 50(11):3476-84 (Pubitemid 39488672)
15. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2002) Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 29(1):62-7 (Pubitemid 34041860)
16. Turesson C, McClelland RL, Christianson TJ, Matteson EL (2007) Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 66(1):70-5 (Pubitemid 46049688)
17. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE (2002) Predictors of infection in rheumatoid arthritis. Arthritis Rheum 46(9):2294-300
18. Iyngkaran P, Limaye V, Hill C, Henderson D, Pile KD, Rischmueller M (2003) Rheumatoid vasculitis following influenza vaccination. Rheumatology (Oxford) 42(7):907-9 (Pubitemid 37220947)
19. Watts RA, Carruthers DM, Scott DG (1995) Isolated nail fold vasculitis in rheumatoid arthritis. Ann Rheum Dis 54(11):927-9
20. Jorizzo JL, Daniels JC (1983) Dermatologic conditions reported in patients with rheumatoid arthritis. J Am Acad Dermatol 8(4):439-57
21. Geirsson AJ, Sturfelt G, Truedsson L (1987) Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis 46(10):727-33 (Pubitemid 17140293)
22. Achkar AA, Stanson AW, Johnson M, Srivatsa SS, Dale LC, Weyand CM (1995) Rheumatoid vasculitis manifesting as intraabdominal hemorrhage. Mayo Clin Proc 70(6):565-9
23. Said G, Lacroix C (2005) Primary and secondary vasculitic neuropathy. J Neurol 252(6):633-41 (Pubitemid 40864035)
24. Boers M, Croonen AM, Dijkmans BAC, Breedveld FC, Eulderink F, Cats A et al (1987) Renal findings in rheumatoid-arthritis - clinical aspects of 132 necropsies. Ann Rheum Dis 46(9):658-63 (Pubitemid 17123497)
25. Radic M, Martinovic Kaliterna D, Radic J (2012) Drug-induced vasculitis: a clinical and pathological review. Neth J Med 70(1):12-7
26. Unger L, Kayser M, Nusslein HG (2003) Successful treatment of severe rheumatoid vasculitis by infliximab. Ann Rheum Dis 62(6):587-8 (Pubitemid 36606297)
27. Puechal X, Miceli-Richard C, Mejjad O, Lafforgue P, Marcelli C, Solau-Gervais E et al (2008) Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Ann Rheum Dis 67(6):880-4 (Pubitemid 351829393)
28. Jones RB, Tervaert JWC, Hauser T, Luqmani R, Morgan MD, Peh CA et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363(3):211-20
29. Assmann G, Pfreundschuh M, Voswinkel J (2010) Rituximab in patients with rheumatoid arthritis and vasculitis-associated cutaneous ulcers. Clin Exp Rheumatol 28(1):S81-S3
30. Puechal X, Gottenberg JE, Berthelot JM, Gossec L, Meyer O, Morel J et al (2012) Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the autoimmunity and rituximab registry. Arthritis Care Res (Hoboken) 64(3):331-9
31. Sumida K, Ubara Y, Takemoto F, Takaichi K (2011) Successful treatment with humanised anti-interleukin 6 receptor antibody for multidrug-refractory and anti-tumour necrosis factor-resistant systemic rheumatoid vasculitis. Clin Exp Rheumatol 29(1):S133-S
32. Fujii W, Kohno M, Ishino H, Nakabayashi A, Fujioka K, Kida T et al (2012) The rapid efficacy of abatacept in a patient with rheumatoid vasculitis. Mod Rheumatol 22(4):630-4
33. Libby P (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 121(10):21-31
34. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J (2005) Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Sem Arth Rheum 35(1):8-17 (Pubitemid 41111466)
35. Sokka T, Abelson B, Pincus T (2008) Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 26(5):S35-S61
36. Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis - an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46(4):862-73 (Pubitemid 34303796)
37. Pasceri V, Yeh ETH (1999) A tale of two diseases - atherosclerosis and rheumatoid arthritis. Circulation 100(21):2124-6
38. Sherer Y, Shoenfeld Y (2006) Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2(2):99-106 (Pubitemid 43239209)
39. del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44(12):2737-45 (Pubitemid 34016192)
40. Kerekes G, Szekanecz Z, Der H, Sandor Z, Lakos G, Muszbek L et al (2008) Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using Imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 35(3):398-406 (Pubitemid 351374411)
41. Kaplan MJ (2009) Management of cardiovascular disease risk in chronic inflammatory disorders. Nat Rev Rheumatol 5(4):208-17
42. Giles JT, Post W, Blumenthal RS, Bathon JM (2006) Therapy insight: managing cardiovascular risk in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol 2(6):320-9 (Pubitemid 43842261)
43. Roubenoff R, Dellaripa P, Nadeau MR, Abad LW, Muldoon BA, Selhub J et al (1997) Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 40(4):718-22 (Pubitemid 27157578)
44. Hannawi S, Marwick TH, Thomas R (2009) Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther. doi: 10.1186/ar2668
45. Hansson GK (2001) Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 21(12):1876-90 (Pubitemid 34219736)
46. Bacons PA, Kitas GD (1994) The significance of vascular inflammation in rheumatoid arthritis. Ann Rheum Dis 53(10):621-3 (Pubitemid 24330594)
47. Del Porto F, Lagana B, Lai S, Nofroni I, Tinti F, Vitale M et al (2007) Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology 46(7):1111-5 (Pubitemid 47050613)
48. Maki-Petaja KM, Elkhawad M, Cheriyan J, Joshi FR, Ostor AJ, Hall FC et al (2012) Anti-tumor necrosis factor-alpha therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation 126(21):2473-80
49. Nurmohamed MT, Kitas G (2011) Cardiovascular risk in rheumatoid arthritis and diabetes: how does it compare and when does it start? Ann Rheum Dis 70(6):881-3
50. John H, Toms TE, Kitas GD (2011) Rheumatoid arthritis: is it a coronary heart disease equivalent? Curr Opin Cardiol 26(4):327-33